Skip to content

Daravimed: what changed

BE 1016.229.804Other company

Position among the sector peers

What moved

Only one financial year

Comparing needs two financial years with figures read. This company has one.

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€159,279 to €215,224

Midpoint €182,589 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €38,829
Capitalised earnings €279,729 to €391,620
Indication €159,279 to €215,224

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€38,829
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€38,829

Capitalised earnings

net result for the year (9904)
2025
€39,162
Average result
€39,162
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€279,729 / €326,350 / €391,620

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.